Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Native T1 Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Amyloidosis

NCT04862273 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT04862273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04862273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Native T1 Cardiac Magnetic Resonance Imaging for Diagnosis of Cardiac Amyloidosis
Lead sponsor
University of Leipzig
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
December 1, 2024
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis, heart failure nyha class ii, heart failure nyha class iii, heart failure nyha class iv, heart failure with mid range ejection fraction, heart failure with preserved ejection fraction, hypertrophy, left ventricular